- Tengion is a leader in the field of regenerative medicine. We are developing new human organs and tissues that are derived from a patient's own cells. ...
- Dr. Nichtberger, a former senior executive at Merck, successful founding entrepreneur, and board certified internist and cardiologist leads the Tengion team ...
- File Format: PDF/Adobe Acrobat - View as HTMLYour browser may not have a PDF reader available. Google recommends visiting our text version of this document.Tengion plans to use the proceeds to fund human clinical trials to advance the ... The funds will also be used to develop Tengion�s manufacturing facility ...
- Tengion plans to use the proceeds from the private stock sale to further the development of its lead products, which are organs and tissues derived from a ...
- Tengion Inc. Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder Enrolling Patients with Urge Incontinence Who Have Failed Alternative ...
- 30 /PRNewswire/ -- Tengion Inc., a clinical stage regenerative medicine company focused on the development of neo-organs and neo-vessels, announced today ...
- Jan 4, 2008 ... Tengion plans to launch a third Phase 2 clinical study of its "Neo-Bladder Augment," a commercial technology based on research conducted by ...
- Oct 18, 2007 ... For most up-and-coming biotech companies, just getting a therapeutic candidate through a proof-of-concept trial and into a licensing deal is ...
No comments:
Post a Comment